Season 9, Episode 52

Listen now:

We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate; a former F.D.A. commissioner who’s been warning of a pandemic for years; and an economist who thinks Covid-19 may finally change how diseases are cured.

To find out more, check out the podcasts from which this hour was drawn: “Will a Covid-19 Vaccine Change the Future of Medical Research?